Lasa Supergenerics - Quaterly Results

14 Aug 2024 Evaluate
The Total revenue for the quarter ended June 2024 of  Rs. 308.36 millions remain, more or less, the same.The Net Loss for the quarter ended June 2024 is Rs. -27.32 millions as compared to Net Loss of Rs. -49.49 millions of corresponding quarter ended June 2023A decline of 18.02 millions was observed in the OP in the quarter ended June 2024 from 40.54 millions on QoQ basis.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202406 202306 % Var 202406 202306 % Var 202403 202303 % Var
Sales 308.36 305.56 0.92 308.36 305.56 0.92 1043.35 1295.68 -19.47
Other Income 0.05 0.04 25.00 0.05 0.04 25.00 0.99 18.05 -94.52
PBIDT 18.02 40.54 -55.55 18.02 40.54 -55.55 22.64 -47.89 -147.28
Interest 8.72 3.73 133.78 8.72 3.73 133.78 19.32 41.60 -53.56
PBDT 9.30 36.81 -74.74 9.30 36.81 -74.74 -84.41 -288.46 -70.74
Depreciation 27.94 26.50 5.43 27.94 26.50 5.43 106.73 134.19 -20.46
PBT -18.64 10.31 -280.80 -18.64 10.31 -280.80 -191.14 -422.65 -54.78
TAX 8.68 59.80 -85.48 8.68 59.80 -85.48 26.18 -36.45 -171.82
Deferred Tax 8.68 59.80 -85.48 8.68 59.80 -85.48 26.18 -36.88 -170.99
PAT -27.32 -49.49 -44.80 -27.32 -49.49 -44.80 -217.32 -386.20 -43.73
Equity 501.01 501.01 0.00 501.01 501.01 0.00 501.01 501.01 0.00
PBIDTM(%) 5.84 13.27 -55.95 5.84 13.27 -55.95 2.17 -3.70 -158.71

Lasa Supergenerics Share Price

9.90 -0.10 (-1.00%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×